SG Americas Securities LLC Sells 23,726 Shares of Proto Labs, Inc. $PRLB

SG Americas Securities LLC trimmed its stake in shares of Proto Labs, Inc. (NYSE:PRLB) by 78.7% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,429 shares of the industrial products company’s stock after selling 23,726 shares during the quarter. SG Americas Securities LLC’s holdings in Proto Labs were worth $367,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Diversified Trust Co increased its holdings in shares of Proto Labs by 12.4% during the first quarter. Diversified Trust Co now owns 11,795 shares of the industrial products company’s stock worth $673,000 after buying an additional 1,300 shares in the last quarter. Hsbc Holdings PLC increased its position in Proto Labs by 45.4% in the 4th quarter. Hsbc Holdings PLC now owns 13,624 shares of the industrial products company’s stock valued at $694,000 after acquiring an additional 4,253 shares during the period. Auto Owners Insurance Co raised its stake in shares of Proto Labs by 4,959.0% during the fourth quarter. Auto Owners Insurance Co now owns 227,655 shares of the industrial products company’s stock valued at $11,517,000 after acquiring an additional 223,155 shares during the last quarter. Invesco Ltd. grew its stake in shares of Proto Labs by 5.2% in the fourth quarter. Invesco Ltd. now owns 107,698 shares of the industrial products company’s stock worth $5,448,000 after purchasing an additional 5,364 shares during the last quarter. Finally, Summit Global Investments bought a new stake in shares of Proto Labs in the 4th quarter valued at about $473,000. Institutional investors own 84.54% of the company’s stock.

Proto Labs Stock Performance

Shares of PRLB stock opened at $75.14 on Friday. Proto Labs, Inc. has a fifty-two week low of $38.48 and a fifty-two week high of $83.15. The stock has a 50 day simple moving average of $74.74 and a two-hundred day simple moving average of $64.09. The company has a market cap of $1.79 billion, a P/E ratio of 70.88 and a beta of 1.38.

Proto Labs (NYSE:PRLB) last announced its quarterly earnings data on Friday, May 1st. The industrial products company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. The company had revenue of $139.34 million during the quarter, compared to the consensus estimate of $135.31 million. Proto Labs had a net margin of 4.71% and a return on equity of 4.15%. The company’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.33 EPS. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. On average, research analysts predict that Proto Labs, Inc. will post 1.37 earnings per share for the current year.

Insider Buying and Selling

In other Proto Labs news, insider Michael R. Kenison sold 16,030 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $69.49, for a total value of $1,113,924.70. Following the transaction, the insider owned 18,683 shares in the company, valued at approximately $1,298,281.67. This represents a 46.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Sven Wehrwein sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total value of $154,560.00. Following the completion of the sale, the director directly owned 32,505 shares of the company’s stock, valued at $2,511,986.40. This trade represents a 5.80% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 25,663 shares of company stock worth $1,804,727. 1.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on PRLB shares. Wall Street Zen upgraded Proto Labs from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 4th. Benchmark upped their target price on Proto Labs from $70.00 to $91.00 and gave the company a “buy” rating in a report on Thursday, July 2nd. Weiss Ratings downgraded shares of Proto Labs from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, June 29th. Finally, Zacks Research downgraded shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 3rd. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Proto Labs currently has a consensus rating of “Moderate Buy” and an average price target of $65.33.

About Proto Labs

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.